Your browser doesn't support javascript.
Comparison of influenza and COVID-19 hospitalisations in British Columbia, Canada: a population-based study.
Setayeshgar, Solmaz; Wilton, James; Sbihi, Hind; Zandy, Moe; Janjua, Naveed; Choi, Alexandra; Smolina, Kate.
  • Setayeshgar S; Data and Analytic Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada solmaz.setayeshgar@bccdc.ca.
  • Wilton J; Data and Analytic Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Sbihi H; Data and Analytic Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Zandy M; School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Janjua N; Public Health Surveillance Unit, Vancouver Coastal Health Authority, Vancouver, British Columbia, Canada.
  • Choi A; Data and Analytic Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Smolina K; School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada.
BMJ Open Respir Res ; 10(1)2023 02.
Article in English | MEDLINE | ID: covidwho-2223677
ABSTRACT

INTRODUCTION:

We compared the population rate of COVID-19 and influenza hospitalisations by age, COVID-19 vaccine status and pandemic phase, which was lacking in other studies.

METHOD:

We conducted a population-based study using hospital data from the province of British Columbia (population 5.3 million) in Canada with universal healthcare coverage. We created two cohorts of COVID-19 hospitalisations based on date of admission annual cohort (March 2020 to February 2021) and peak cohort (Omicron era; first 10 weeks of 2022). For comparison, we created influenza annual and peak cohorts using three historical periods years to capture varying severity and circulating strains 2009/2010, 2015/2016 and 2016/2017. We estimated hospitalisation rates per 100 000 population.

RESULTS:

COVID-19 and influenza hospitalisation rates by age group were 'J' shaped. The population rate of COVID-19 hospital admissions in the annual cohort (mostly unvaccinated; public health restrictions in place) was significantly higher than influenza among individuals aged 30-69 years, and comparable to the severe influenza year (2016/2017) among 70+. In the peak COVID-19 cohort (mostly vaccinated; few restrictions in place), the hospitalisation rate was comparable with influenza 2016/2017 in all age groups, although rates among the unvaccinated population were still higher than influenza among 18+. Among people aged 5-17 years, COVID-19 hospitalisation rates were lower than/comparable to influenza years in both cohorts. The COVID-19 hospitalisation rate among 0-4 years old, during Omicron, was higher than influenza 2015/2016 and 2016/2017 and lower than 2009/2010 pandemic.

CONCLUSIONS:

During first Omicron wave, COVID-19 hospitalisation rates were significantly higher than historical influenza hospitalisation rates for unvaccinated adults but were comparable to influenza for vaccinated adults. For children, in the context of high infection levels, hospitalisation rates for COVID-19 were lower than 2009/2010 H1N1 influenza and comparable (higher for 0-4) to non-pandemic years, regardless of the vaccine status.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H1N1 Subtype / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Adult / Child / Child, preschool / Humans / Infant / Infant, Newborn Country/Region as subject: North America Language: English Year: 2023 Document Type: Article Affiliation country: Bmjresp-2022-001567

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Influenza Vaccines / Influenza, Human / Influenza A Virus, H1N1 Subtype / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines / Variants Limits: Adult / Child / Child, preschool / Humans / Infant / Infant, Newborn Country/Region as subject: North America Language: English Year: 2023 Document Type: Article Affiliation country: Bmjresp-2022-001567